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Abstract The modification of intracellular redox conditions
with diethylmaleate (DEM), a glutathione-depleting agent,
induces a p53-independent growth arrest mediated by the
accumulation of p21waf1 mRNA and protein. The same treatment
also induces the retinoblastoma protein (pRb) dephosphorylation.
This dephosphorylation (i) is very fast, being observed already
5 min after the exposure of the cells to DEM, (ii) is dependent on
the prooxidant effects of DEM, being prevented by the treatment
with N-acetylcysteine and (iii) is completely reversible, since the
rephosphorylation of pRb is promptly obtained upon the removal
of the glutathione-depleting agent from the culture medium. The
dephosphorylation of pRb is independent of the accumulation of
p21waf1 induced by DEM; in fact, p21waf1 levels start to increase
much later after DEM treatment and accordingly cyclin-
dependent kinase activities are not yet induced when pRb is
already dephosphorylated following DEM treatment. Finally,
pRb dephosphorylation is catalyzed by phosphatases activated by
DEM treatment.
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1. Introduction
Reactive oxygen species (ROS) have been studied for a long
time only as agents able to in£ict damage on DNA, proteins
and fatty acids [1^3]. This damage often leads, depending on
the length and the extent of the exposure, to cell death or to
cell transformation as a consequence of gene mutation. More
recently, several results suggest some possible physiologic
roles for ROS, namely as mediators of extracellular signal
transduction and/or as regulators of cell cycle progression
[4,5]. We previously demonstrated that the increase of ROS
concentration, due to glutathione (GSH) depletion induced by
diethylmaleate (DEM), induces an accumulation of p21waf1
[6].
This protein is an inhibitor of several cyclin-dependent ki-
nases (CDK), which regulate cell cycle progression, and is the
main target of p53 tumor suppressor. In fact p53, activated by
di¡erent events including genome damage, induces the tran-
scription of the p21waf1 gene and in turn the increase of
p21waf1 protein concentration [7]. However, our results dem-
onstrated that the ROS-induced p21waf1 accumulation is in-
dependent of p53 activation [6] which, on the contrary, seems
to be inhibited in our experimental conditions [6], whereas the
phenomenon that we observed requires the activation of the
ras-MAPK pathway and does not depend upon p21waf1 gene
transcription [8].
As expected, the e¡ect of the observed increase of p21waf1
concentration is the accumulation of cells in the G1 phase [6].
In fact, G1CS transition is based on the release of E2F tran-
scription factors from the complex in which they are bound to
the retinoblastoma protein (pRb). This release is the conse-
quence of pRb phosphorylation which is catalyzed by CDKs,
therefore the accumulation of p21waf1 inhibits pRb phosphor-
ylation, thus blocking E2F release and the G1CS transition
[9,10].
Another possible mechanism a¡ecting pRb phosphorylation
could be based on the e¡ect of protein phosphatases. We
previously demonstrated that a short exposure of cultured
cells to DEM leads to the dephosphorylation of p21waf1 as
demonstrated by the appearance in Western blots decorated
with anti-p21waf1 antibody, of a faster migrating band [11].
Several results suggest that this early phenomenon could be
due to the activation of protein Ser^Thr phosphatases by
ROS [11]. Therefore, it is conceivable to hypothesize that
ROS could cause the dephosphorylation of other proteins,
through the activation of those protein phosphatases.
Herein we report the results showing that the dephosphor-
ylation of pRb is an early event which follows the modi¢ca-
tion of intracellular redox conditions induced by DEM, thus
indicating that intracellular ROS concentrations a¡ect cell
cycle progression through multiple mechanisms which also
include the activation of Ser^Thr phosphatases.
2. Materials and methods
2.1. Cell lines and materials
Human pro-myelocytic leukemia cells (HL60) were cultured in
RPMI 1640 medium (Gibco-BRL) containing 10% fetal calf serum
(FCS, ICN), 2 mM glutamine, 100 units/ml penicillin and 100 mg/
ml streptomycin; COS7 cells were grown in Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM) supplemented with 10% FCS (ICN), 100
units/ml penicillin and 100 mg/ml streptomycin. Both cell lines were
grown at 37‡C in a 5% CO2 atmosphere.
Anti-p21waf1 (sc-397), anti-cyclins A (sc-751) and B1 (sc-245) poly-
clonal antibodies and anti-E2F1 (sc-251) monoclonal antibody were
from Santa Cruz Biotechnology. Anti-retinoblastoma (Rb) monoclo-
nal antibody was from Pharmingen. H1 histone was from Boehringer.
DEM and N-acetylcysteine (NAC) were from Sigma. DEM was added
directly to the culture medium into the dishes from the concentrated
solution to reach a ¢nal concentration of 1 mM. NAC was dissolved
in phosphate bu¡ered saline (PBS) solution at a ¢nal concentration of
30 mM.
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2.2. Western blot and immunoprecipitation analyses
Protein extracts were obtained by lysing the cells on ice in a bu¡er
containing 1.6 mM KH2PO4, 12.5 mM K2HPO4; 1% Tryton, 3.4 mM
SDS, 0.1 M NaCl, 11.5 mM Na-deoxycholate, 0.1% sodium azide, 50
mM sodium £uoride, 1 mM sodium orthovanadate, 10 mM sodium
pyrophosphate and 1 mM phenylmethylsulfonyl £uoride (PMSF),
1 Wg/ml each of aprotinin, leupeptin and pepstatin. Extracts used
for Western blotting were obtained by centrifuging the lysate at 4‡C
at 1000Ug for 10 min. For the immunoprecipitation experiments,
con£uent dishes were washed twice with PBS and the cells were lysed
by the addition of 800 Wl bu¡er containing 10 mM Tris^HCl, pH 7.5,
150 mM NaCl; 0.1 mM EDTA, 1 mM sodium orthovanadate, 50 mM
sodium £uoride and 0.5% NP40, 1 mM PMSF and 1 Wg/ml aprotinin,
leupeptin and pepstatin. Cells were rocked at 4‡C for 30 min and
collected by centrifugation (4000 rpm for 10 min) at 4‡C. The protein
concentration was determined by using the Bradford method (Bio-
Rad); for the immunoprecipitates 0.5^1 mg protein extracts were in-
cubated with 1 Wg anti-Rb antibody overnight at 4‡C, centrifuged and
the pellets washed in the lysis bu¡er without protease inhibitors. Fifty
Wg aliquots of proteins for Western blots and immunoprecipitates
were loaded and electrophoresed through a SDS^polyacrylamide gel
(polyacrylamide gel concentrations were 13 and 8% for p21 and pRb,
respectively) and then transferred to Immobilon-P transfer mem-
branes (Millipore); the incubation with anti-p21waf1 antibody and
with anti-Rb were according to the manufacturers. After incubation
with rabbit horseradish peroxidase-conjugated secondary antibody,
the blots were developed using enhanced chemiluminescence (Amer-
sham). The H1 kinase assay was performed as described [12].
2.3. Cell free dephosphorylation assays
HL60 cells were pretreated with DEM for the indicated times.
Whole cell extracts and immunoprecipitates were prepared immedi-
ately after treatment, as described in Section 2. For the cell free pRb
dephosphorylation assays aliquots (50 Wg) of protein per reaction or
an immunoprecipitate (from 0.5^1 mg of protein) were suspended in
PBS and incubated at 0 and 30‡C for the indicated times. For p21waf1
in vitro dephosphorylation by pRb-associated phosphatase, pRb im-
munoprecipitates were prepared from untreated and DEM pretreated
HL60 cells and incubated at 0 and 30‡C with aliquots (50 Wg) of
COS7 protein extract as a source of p21waf1. After this incubation,
the reactions were terminated by the addition of Laemmli bu¡er and
the Western blot was performed with the antibodies indicated in the
¢gure legends.
3. Results and discussion
We previously showed that the exposure of cultured cells to
DEM, a GSH-depleting agent, leads to two phenomena: an
early event, represented by the dephosphorylation of p21waf1
already evident 5 min after the exposure to DEM, and a late
event, consisting of the progressive accumulation of p21waf1
starting to be detectable 2-3 h after the exposure to DEM [6].
To explore the phosphorylation state of pRb following DEM
treatment, HL60 cells were exposed for di¡erent times to var-
ious concentrations of DEM and protein extracts from these
cells were analyzed by Western blotting with anti-pRb anti-
body. As shown in Fig. 1A, the Western blot of the extracts
from untreated cells shows several bands recognized by the
anti-pRb antibody. Slower and faster migrating bands are
known to correspond to the hyper- and hypophosphorylated
forms of pRb, respectively, considering that the alkaline phos-
phatase treatment abolishes the slower migrating bands and
increases the amount of the fastest bands [13]. In the extracts
from cells exposed to DEM, this shift of band migration to-
ward the faster bands is already present after 5 min of treat-
ment and progressively became more evident up to 1 h. To
ascertain whether the observed phenomenon is caused by the
modi¢cation of the intracellular redox conditions induced by
DEM, HL60 cells were treated, before the exposure to DEM,
with a GSH-precursor, N-acetylcysteine (NAC), which is well
demonstrated to counteract the e¡ects of DEM [6]. As shown
in Fig. 1B, NAC pretreatment completely prevents the mod-
i¢cation of pRb electrophoretic migration pattern. This ex-
periment strongly supports the hypothesis that the observed
phenomenon is a consequence of the modi¢cation of intra-
cellular redox conditions. However, it must be noted that, at
very early times, no signi¢cant modi¢cation of intracellular
ROS concentration was observed (data not shown), thus sug-
gesting either that very small changes of ROS concentration
are already able to induce the phenomenon or that DEM acts
by increasing ROS concentration only in speci¢c cellular com-
partments. In any case, it is evident that the observed shift of
bands towards the faster migrating ones is completely and
Fig. 1. Oxidative stress induces an early and reversible retinoblasto-
ma protein (pRb) dephosphorylation. Panel A: HL60 cells were ex-
posed to 1 mM DEM and harvested for protein extract preparation.
The protein extracts were prepared as described in Section 2 and
analyzed by Western blotting with anti-pRb antibody. Lane a, un-
treated cells ; lanes b to e, cells treated with 1 mM DEM for the in-
dicated times. Panel B: HL60 cells were pretreated with 30 mM
NAC for 1 h and then with 1 mM DEM for 30 min. The cellular
extracts were analyzed by Western blotting with anti-pRb antibody.
Lane a, untreated cells; lanes b and c, cells treated with DEM; lane
c, cells pretreated with NAC. Panel C: HL60 cells were treated with
1 mM DEM for 30 min. The cellular extracts were analyzed by
Western blotting with anti-pRb antibody. Lane a, untreated cells ;
lane b, cells treated with DEM for 30 min; lane c, lane treated with
DEM for 30 min, extensively washed with culture medium to re-
move DEM, incubated in fresh medium and harvested 30 min later
for the preparation of cellular extracts.
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rapidly reversible upon the removal of DEM. In fact, as
shown in Fig. 1C, in HL60 cells exposed to DEM for 30
min, then washed with fresh culture medium for an additional
30 min, a complete recovery of the pRb electrophoretic pat-
tern was observed. This excludes the possibility that the mod-
i¢cation of the pRb pattern is a consequence of chemical
modi¢cation of the protein by ROS, which are known to be
generally irreversible [14].
The hypophosphorylated form of pRb is associated to E2F,
while pRb phosphorylation causes the release of E2F from the
complex and in turn the G1CS transition is allowed [9,10].
Therefore, we asked whether following the dephosphorylation
of pRb upon DEM treatment, an increased amount of E2F
complexed to pRb is found. Fig. 2A shows that at early times
of DEM exposure pRb dephosphorylation does not lead to an
increased E2F association, whereas increased amounts of
E2F/pRb complexes are observed, as expected, after 1.5 and
3 h of DEM exposure, probably as a consequence of CDK
inhibition by p21waf1. This observation deserves further anal-
ysis aimed to evaluate the amino acid residues of pRb dephos-
phorylated as a consequence of the exposure to DEM, that
could not be involved in the regulation of Rb/E2F interac-
tions. Interestingly, treatment of HL60 cells with DEM a¡ects
also E2F protein: in fact, an inverted ratio between the upper
and the lower bands in extracts from untreated and DEM-
treated cells is observed (Fig. 2A, lanes a and b). However,
both E2F forms are involved in pRB binding. These results
suggest that another dephosphorylation process, analogous to
pRb dephosphorylation, takes place upon DEM treatment for
E2F transcription factor.
An important point to be addressed concerns the mecha-
nism through which DEM induces the dephosphorylation of
pRb. pRb dephosphorylation could be due to the induction of
p21waf1 and the consequent inhibition of kinase activities
which phosphorylate pRb or to an induction of protein Ser^
Thr phosphatase activities. Since we observed that p21waf1
accumulation, which follows DEM treatment, is a late phe-
nomenon, compared to the observed pRb dephosphorylation,
it seems unlikely that this dephosphorylation can be a conse-
quence of CDK inhibition. However, we measured the
changes of cyclin A- and cyclin B1-associated kinase activities,
as an indirect measurement of p21waf1-induced inhibition.
During the ¢rst 30 min of incubation of HL60 cells with
DEM we did not observe any change of cyclin/CDK activity,
as demonstrated by the phosphorylation levels of H1 histone
used as a substrate of the cyclin A (Fig. 3, lane b versus lane
a) and cyclin B1 immunocomplexes (Fig. 3, lane f versus lane
e). On the contrary, appreciable inhibition of the kinase ac-
tivity was observed 2 and 4 h after DEM exposures (Fig. 3,
lanes c and d versus lane a for cyclin A and lanes g and h
versus lane e for cyclin B1) and this is in agreement with the
timing of p21waf1 accumulation that follows DEM treatment
[6].
The lack of a measurable inhibition of CDK activities, even
30 min after the exposure of cells to DEM, suggests the pos-
sibility that pRb dephosphorylation could be due to the acti-
Fig. 2. Treatment of HL60 cells with DEM induces an increased as-
sociation of E2F transcription factor to pRB. Panel A: HL60 cells
were treated with 1 mM DEM and then harvested for the prepara-
tion of cellular extracts. The cellular extracts were analyzed by
Western blotting with anti-E2F1 antibody (lanes a and b) or immu-
noprecipitated with anti-pRb antibody and analyzed by Western
blotting with anti-E2F1 antibody (lanes c^g). Lane a, untreated
cells ; lane b, cells treated with 1 mM DEM for 3 h; lane c, un-
treated cells ; lanes d to g, cells treated with 1 mM DEM for the in-
dicated times. Panel B: HL60 cells were treated with 1 mM DEM
and then harvested for the preparation of cellular extracts. The cel-
lular extracts were analyzed by Western blotting with anti-pRb anti-
body (lanes a and b) or immunoprecipitated with anti-pRb antibody
and analyzed by Western blotting with anti-pRb antibody (lanes c^
g). Lane a, untreated cells ; lane b, cells treated with 1 mM DEM
for 3 h; lane c, untreated cells ; lanes d to g, cells treated with 1 mM
DEM for the indicated times.
Fig. 4. pRb dephosphorylation under cell-free conditions. HL60
cells were treated with 1 mM DEM for 5 min and then harvested
for the preparation of cellular extracts. The cellular extracts were
analyzed by Western blotting with anti-pRb antibody. Lanes a and
b: cellular extracts from untreated (lane a) and DEM-treated (lane
b) HL60 cells were incubated at 0‡C for 90 min; lanes c and d: cel-
lular extracts from untreated cells (lane c) and DEM-treated cells
(lane d), were incubated at 30‡C for 90 min.
Fig. 3. E¡ects of DEM treatment on the inhibition of cyclin A and
cyclin B1 activity by p21waf1. HL60 cells were exposed to 1 mM
DEM for the indicated times and harvested for the preparation of
cellular extracts and immunoprecipitates as described in Section 2.
Lanes a^d, extracts were immunoprecipitated with anti-cyclin A
antibody; lanes e^h, extracts were immunoprecipitated with anti-cy-
clin B1 antibody. Lanes a and e, untreated cells; lanes b and f, cells
treated with DEM for 30 min; lanes c and g, cells treated with
DEM for 2 h; lanes d and h, cells treated with DEM for 4 h.
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vation of protein Ser^Thr phosphatases. If this is the case we
should observe that the dephosphorylation of pRb continues
in vitro on incubation under the proper conditions. To test
this point, protein extracts from untreated HL60 cells or from
cells treated with DEM for 5 min were incubated at 0 or 30‡C
for 90 min. As shown in Fig. 4, DEM-dependent pRb dephos-
phorylation is more evident in cell extracts kept at 30‡C for 90
min (lane d) than in the extracts kept at 0‡C for 90 min (lane
b). This observation is clearly DEM-dependent, because no
dephosphorylation was observed in the extracts from cells
not exposed to DEM (lanes a and c).
The dephosphorylation of pRb by protein phosphatases
was also demonstrated under di¡erent experimental condi-
tions [15,16]. In the case of treatment with anticancer drugs,
these phosphatase activities were found to be associated with
pRb itself, as demonstrated by co-immunoprecipitation ex-
periments with anti-pRb antibodies [15]. Considering that
we already demonstrated a DEM-induced dephosphorylation
of p21waf1 upon the increase of ROS levels [11], it could be
hypothesized that the p21waf1 dephosphorylation is due to the
phosphatase activities associated with pRb protein. To ad-
dress this point, pRb immunoprecipitates were prepared
from untreated and DEM-treated HL60 cells and incubated
with protein extracts from COS 7 cells, that contain consid-
erable amounts of p21waf1, at 30‡C for 90 min. Fig. 5A shows
the Western blot of these incubation mixtures with anti-
p21waf1 antibody; the p21waf1 dephosphorylation was observed
only in samples from DEM-treated cells (lane d), while no
p21waf1 dephosphorylation was observed when the samples
from DEM-treated cells were kept on ice (lane b) or when
immunoprecipitates from untreated control cells were incu-
bated at 30‡C (lane c). To evaluate whether a similar phos-
phatase activity is also associated to p21waf1 we immunopre-
cipitated protein extracts from DEM-treated COS7 cells with
anti-p21waf1antibodies and incubated these immunoprecipi-
tates with extracts from untreated HL60 cells. As reported
in Fig. 5B, the Western blot of these extracts with anti-pRb
antibodies shows that neither at 0‡C nor at 30‡C is pRb
migration a¡ected by the exposure to anti-p21waf1 immuno-
precipitates. This demonstrates that p21waf1 immunoprecipi-
tated from COS7 cells is not associated with phosphatases.
In summary, the results reported in this paper provide evi-
dence for the ability of intracellular redox changes to cause an
early dephosphorylation of pRb. This phenomenon precedes
the accumulation of p21waf1 that leads to the inhibition of
CDK activity. The two e¡ects act synergistically to obtain
the dephosphorylation of pRb and to avoid its rephosphory-
lation by CDKs. However, in cells exposed to oxidants, the
early dephosphorylation of pRb does not lead to the seques-
tration of E2F in the dephospho-pRb/E2F complexes. This
does not exclude that the early pRb dephosphorylation caused
by DEM could a¡ect other pRb function.
While protein kinase activities regulating the response to
mitogenic stimuli and cell cycle progression are well known,
less information is available on protein phosphatases which
are expected to contribute, to the same extent as the kinases,
to the regulation of these phenomena. The experimental sys-
tem that we used appears to be suitable to study the regula-
tion of these protein phosphatases and their role in the mo-
lecular machinery responsible for the control of cell
proliferation.
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